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Introduction 
In South Africa, human immunodeficiency virus (HIV) 
remains a major cause of morbidity and mortality among 
adults and children. In 2009, the estimated adult prevalence 
of HIV was 5.24 million (meaning that 10.6% of the total 
population was HIV positive). The estimated number 
of children under 15 years of age who are HIV infected is 
330 000. The annual number of new infections among 
children is estimated to be 40 000.1 The number of children 
in need of antiretroviral therapy (ART) doubled between 
2005-2010, and by 2009, it was estimated that 86 270 
children were receiving ART.2
HIV is associated with many symptoms, of which pain can 
be particularly problematic. Pain may be caused directly by 
the virus, which has a predilection for nerve tissues. Both 
the peripheral and central nervous systems are frequently 
affected in patients with HIV.3 Pain can also be caused 
indirectly by opportunistic infections associated with HIV 
and malignancies.4 In adults with HIV, pain is a frequently 
reported symptom throughout all stages of the disease. 
Patients report headaches, mouth and throat pain, chest 
pain, myalgia, arthralgia, as well as the pain associated 
with medical procedures.4 Similar to findings on patients 
suffering from cancer, pain in patients with HIV is frequently 
not recognised by healthcare providers, and when 
acknowledged, is often undertreated.5 
In southern Africa (Botswana, Lesotho, South Africa and 
Swaziland), a study among 743 adults with HIV disease 
reported that pain was a common symptom that required 
care.6 A high pain prevalence among adults has been shown 
to be associated with advanced HIV disease in South Africa. 
For example, in a hospice-based study among 103 adult 
patients with World Health Organization Stage 4 acquired 
immune deficiency syndrome (AIDS), carried out in 2003, 
98% of patients reported pain, of whom the majority were 
not receiving ART.7 A rural community-based study, carried 
out in 2002, indicated that pain was commonly reported 
Abstract 
Background: Patients with human immunodeficiency virus (HIV) disease on antiretroviral therapy (ART) may experience 
pain for a variety of reasons, including the effects of the virus itself, associated opportunistic infections and the ART. Studies 
indicate that pain in adults on ART is frequent, can be severe, and is often undertreated. This study sought to explore the 
experience, and the prevalence of pain in young children aged 3-13 years on ART.
Method: Primary caregivers of children aged 3-13 years on ART attending a paediatric ART clinic at a regional hospital 
in Durban participated in the study. Convenience sampling was used. The Wong-Baker FACES™ Pain Rating Scale and a 
questionnaire adapted from Hirshefeld were used to investigate variables such as age, cluster of differentiation 4 (CD4) 
count, ART regimen, ART duration, and site, prevalence and impact of pain during activities. Data were analysed using a 
standard statistical programme.  
Results: Four hundred and twenty primary caregivers were interviewed. Most were mothers caring for their HIV-positive 
children, and the majority of the children were aged 3-7 years. Most children were on a first-line ART regimen, and half 
reported pain. Nociceptive pain (visceral or somatic) was the most common type of pain, and pain interfered with the daily 
activities of a third of the children. There was a significant association between CD4 count and pain (p-value = 0.040). 
Paracetamol was the most commonly used analgesic. 
Conclusion: Pain was a common problem, and generally was undertreated with analgesia. A need to improve pain 
assessment and management in this population group was identified.  
 Peer reviewed. (Submitted: 2011-08-24. Accepted: 2012-02-01.) © SAAFP  S Afr Fam Pract 2012;54(4):358-362
Exploration of pain in children on antiretroviral treatment  
in a regional hospital in South Africa
Azam M, MBBS, DCH(SA), Clinical Manager, Paediatirics, Prince Mshiyeni Memorial Hospital, Durban 
Campbell L, MBChB, MMed, MPhil, PhD, Specialist 
Ross A, MBCHB, DCH, MFamMed, Principal Specialist
Department of Family Medicine, Nelson R Mandela School of Medicine, University of KwaZulu Natal, Durban
Correspondence to: Muhammad Azam, e-mail: mazam@telkomsa.net
Keywords: HIV, ART, pain, children, caregiver
Original Research: Exploration of pain in children on antiretroviral treatment in a regional hospital, South Africa
359 Vol 54 No 3S Afr Fam Pract 2012
Original Research: Exploration of pain in children on antiretroviral treatment in a regional hospital, South Africa
among HIV-infected adults who were not on ART.8 Pain 
has also been found to be prevalent among HIV-positive 
outpatients, as indicated in a study conducted in Pretoria 
among 354 HIV-positive outpatients who were not on ART, 
in which 62% of patients reported significant pain, and 
20.9% patients reported severe neuropathic pain, that was 
assumed to be due to HIV. These patients reported that pain 
interfered with their quality and enjoyment of life, and their 
moods and ability to work.9 
In South Africa, studies on pain prevalence in children 
on ART have been slow to emerge. In a Western context, 
Hirschfeld et al reported a pain incidence of 59% in 
children with HIV infection, as compared to an incidence 
of 47% in children with cancer.10 Various types of pain have 
been recorded in children with HIV, including headaches, 
abdominal pain, myalgia, peripheral neuropathy, chest pain, 
and oral cavity pain.11 
Barriers to recognition and treatment of pain in children 
by healthcare providers may be considerable. Despite 
education and research to the contrary, misconceptions 
regarding pain perception in children persist.12 For example, 
studies indicate that some clinicians believe that young 
children do not experience pain, as there is an incorrect 
view that nerve cell myelination is incomplete in infants and 
young children. Therefore, the belief is that children do not 
experience the same kind or intensity of pain as adults, 
and do not need pain prevention or pain relief. A second 
misconception is that children do not remember painful 
experiences.13 A third misconception around pain in children 
lies in an assumption that pain is not a prevalent problem, 
as children cannot describe a source or type of pain. It is 
true that children may not have the same vocabulary as 
adults, and may experience difficulty in verbalising issues 
around pain. However, a clinician can gain awareness of 
pain in children by studying non-verbal communication.14 
Like adults, children on ART may experience pain due to 
HIV infection itself, opportunistic infections, the side-effects 
of drugs and therapeutic procedures.10,11,15 
Assessment and management of pain in children on ART 
should form a major focus of clinical intervention. In 2002, 
the Paediatric AIDS Clinical Trial Group (PACTG219) found 
a significant association between pain and mortality in 
children. The researchers reported that children who 
reported pain were five times at greater risk of dying, than 
those who did not report pain.16
The effective assessment and treatment of pain in children 
with HIV/AIDS can be challenging. Developing an appropriate 
pain management strategy may include pharmacological 
and nonpharmacological therapies, tailored to a child’s age, 
development, culture, type of pain, and past experience. 
With regard to assessing pain in children, studies have 
indicated that in the case of a young child, the primary 
caregiver can report symptoms, including pain, on behalf of 
a young child, and that there is a strong correlation between 
what the caregiver reports, and the child’s experience of 
pain.10-17 Most studies of pain in children with HIV infection 
have been conducted in first world countries, and the 
results of such studies cannot be directly transcribed to a 
South African setting. This study aimed to explore pain in 
young children who have HIV disease, and who are taking 
ART in a South African regional hospital. 
Method
This was a descriptive and exploratory study. Ethical 
permission was granted by the University of KwaZulu-Natal 
Research Ethics Committee (REC.290408-009). Written 
permission was obtained from all participants. 
Study site
The study was set in an ART clinic that is affiliated to a 
regional level hospital in KwaZulu-Natal. The paediatric 
section of the clinic provides ART to children from birth until 
13 years of age. This site was chosen as a large number of 
young children on ART present there. 
Subject and sampling
At the time of the study, 1 400 children were receiving 
ART at the paediatric ART clinic. Caregivers attending the 
ART clinic with a young child (aged 3-13 years) were given 
information about the study, and invited to participate. 
Caregivers with a child who was younger than three years 
of age, or with a child who was acutely ill, or those who 
refused to participate, were excluded from the study. The 
primary caregiver was defined as the person who cared for 
the child most of the time, and who was 18 years of age or 
older. On designated days between July and October 2010, 
the researchers interviewed caregivers at the clinic, until 420 
caregivers had been interviewed. A Zulu-speaking nurse 
explained the nature of the study, provided information 
on confidentiality and consent, and was available for 
translation when required. Charts were marked to ensure 
that caregivers only participated once. Although the sample 
was convenient in nature, the sample was considered 
appropriate as this study does not make any claims towards 
reliability or generalisability. It simply explored whether 
further study in this topic might be warranted. 
Data collection tools
Assessing pain is an essential step when developing a 
management plan, and a holistic assessment of pain 
involves observation of the child and discussion with 
parents and other caregivers. There are numerous formal 
tools for assessing pain in children that are appropriate for 
differing ages and development levels. 
The Wong-Baker FACES™ Pain Rating Scale (WBFS), 
which has been tested in many developed and developing 
countries and is considered to be a valid and reliable pain 
assessment tool, was used in this study.18 The WBFS has 
been developed for children over the age of three, and 
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depicts six faces that are numbered 0, 2, 4, 6, 8, and 10. The 
first picture (0) presents a picture of a smiling face, and the 
last picture (10) presents a picture of a grimacing, distressed 
face with tears. The tool was initially developed for young 
preverbal children, so that they could point to a face that 
they felt best represented the effects of pain. A score of 4 or 
greater is associated with significant pain.19 In this study, the 
caregivers of young children were asked to score their child’s 
pain on the WBFS, and thus the tool was used in a way other 
than that for which it was designed. The researchers made 
a decision to focus on the opinions provided by caregivers 
about the level of  pain experienced by their children, rather 
than those of the children themselves, as the WBFS has 
not been validated in South Africa.14 However, other studies 
have shown that there is good concordance between the 
caregiver’s assessment of a child’s pain, and the child’s pain 
score.10,17,20 To get a general idea of the pain experienced 
by young children on ART, the WBFS was incorporated into 
a questionnaire developed by Hirschfeld.10 Hirschfeld et al 
studied pain in children who were HIV positive, and their 
questionnaire considered a number of variables, including 
the site and duration of pain, and impact of pain on activity 
and sleep. In this study, the questionnaire was modified to 
capture data on the relation of the caregiver to the child, 
the child’s age, CD4 count, ART regimen, and duration of 
ART. The child’s clinic record was used to obtain data on 
CD4 count, ART regimen and duration of treatment, and an 
interview was conducted to complete the WBFS and gather 
other information.
Data analysis
For the purpose of this study, positive responses for pain 
were tabulated, and point prevalence was calculated. 
Responses relating to the quality-of-life questionnaire were 
rated on a five-point scale (“never” = 0, “rarely” = 1, “some-
times” = 2, “often” = 3, and “all the time” = 4). A rating of 2 
or more was taken as significant. Data were captured and 
analysed using the Statistical Package for Social Science®. 
Data were summarised by descriptive statistics. Inferential 
analysis was carried out, and a p-value of < 0.05 was con-
sidered to be significant.
Results
Four hundred and twenty primary caregivers were 
interviewed: 226 (53.8%) mothers, and 102 (24.3%) 
grandmothers, as illustrated in Table I. The age of the 
children ranged from 3-13 years, with an average of 7.19 
years. Most of the children (233: 55.5%) were 3-7 years old, 
and 187 (44.5%) were 8-13 years old.
Just under half (43.1%) had a CD4 percentage of > 25%. 
A fifth had a CD4 percentage of < 15% (which implies 
severe immunosuppression). Most of the children were on 
a first-line regimen (411: 97.9%), with only nine (2.1%) on 
an alternative regimen of ART. Most started treatment after 
2006 (79.5%).
Under half of the primary caregivers indicated that their 
children experienced some pain (scored > 2 on the WBFS) 
at the time of the interview (188: 44.8%). The pain was 
estimated by the caregiver as greater than 4 on the WBFS 
in a third of the children (141: 33.5%). Generally, intensity 
of more than 4 is considered to be significant pain. There 
was no difference in the mean age of the children who 
experienced pain, and those who did not: 7.40 and 6.96 
years respectively (p-value = 0.123). 
Table II summarises the relationship between age and pain 
> 2 on the WBFS. 
Table II: Relationship between age and pain (> 2 on the Wong-Baker 
FACES™ Pain Rating Scale) 
Age in months Pain > 2 on WBFS %
36–60 (3-5 years) 86 46
60–84 (5-7 years) 28 15
84–108 (7-9 years) 39 21
108–156 (9-13 years) 35 18
Total 188 100
A third of the caregivers reported that pain was present 
for at least eight hours during a 24-hour period, and that 
pain was present while resting. A third of the caregivers 
(29.3%) reported that pain interfered with daily and physical 
activities, such as walking, playing and running. In 10.6%, 
pain was also related to other activities, for example, 
swallowing. 
Table I: Demographic and clinical data summary








Other (father, uncle, brother, sister or cousin) 34 8.2
Age of children
3-7 years 233 55.5
8-13 years 187 44.5
CD4 percentage
< 15% 86 20.5
15-25% 133 31.7
> 25% 181 43.1
Antiretroviral treatment regimen
Stavudine, lamivudine, lopinovir/ritonavir 71 16.9
Stavudine, lamivudine, efavirenz 314 74.8
Abacavir, lamivudine, efavirenz   26 6.2
Alternative regimen 9 2.1
Duration of antiretroviral treatment (years)*
0-3 years   355 79.8%
> 3 years      68 16.4%
* Some data were missing from the records
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Table III summarises the temporal aspect of pain, and the 
effect of pain on daily activities. Table IV summarises the 
reported sites of pain.  
Table III: Temporal aspects of pain and effect of pain on daily activity
Features of pain n %
Pain > 2 on WBFS 188 44.8
Pain > 4 on WBFS 141 33.5
Duration of pain > 8 hours 161 38.4
Pain while resting, or sleep disturbance due to 
pain
151 36.4
Pain during activity 121 29.3
Pain related to swallowing 45 10.6
Table IV: Reported sites of pain




Abdominal pain 28 6.7
Chest pain 27 6.4
Body pain 22 5.2
Earache 21 5.0
Nose pain 5 1.2
Painful gums 2 0.5
Mouth pain 1 0.2
Painful limbs and feet (peripheral neuropathy) 16 3.8
Genital pain (warts) 3 0.7
Painful lymph nodes 2 0.4
Backache 1 0.2
Joint pain 2 0.5
Nociceptive pain (visceral or somatic) was most commonly 
described (40.2%), while painful limbs and feet (which the 
researcher made an assumption to be neuropathic pain) 
were found in 16 (3.8%) children. 
There was a significant association between CD4 count 
and pain (p-value = 0.040). Those with a CD4 percentage 
> 25% reported less pain than those with a CD4 percentage 
< 25%. Paracetamol was the most commonly used analgesics 
(66.7%). Among the children with assumed neuropathic pain, 
only a minority (3%) were on medication that might improve 
neuropathic pain (such as amitriptyline), and the remainder 
were not on any pain medication. Other medications that 
were dispensed as a form of analgesia included the local 
application of cream, and the use of nebulisation with 
β2 agonists for chest pain. 
Discussion
A quarter of the caregivers were grandmothers, and this may 
reflective of the high proportion of HIV-positive children who 
are being cared for by elderly caregivers in this population. 
These caregivers often care for a number of young children, 
and ART education, adherence counselling and support 
must consider that the caregiver may be elderly and have 
his or her own health issues.21
It is of concern that half of the caregivers reported that their 
children experienced pain, and this finding is comparable 
with the findings of other studies.10,17,20 A limitation of this 
study is that the data collection tool did not consider the 
length of time that the pain had been present, and so it is 
not possible to say whether it was acute or chronic. This 
distinction is critical, as the management of acute pain 
differs greatly from the management of chronic pain.22 Acute 
pain tends to resolve when the acute problem is treated. For 
example, earache will resolve when otitis media is treated. 
Chronic pain may be more difficult to assess and treat in 
young children. 
A third of the participants reported that their children 
experienced pain for at least eight hours in a 24-hour 
period. Thirty-six per cent reported pain while resting or 
sleep disturbance, 29.3% reported activity-related pain 
(either walking or running), and 10.6% reported pain on 
swallowing. Other studies have shown that typically, pain 
that is associated with activities limits the participation 
of children in physical activities, and restricts their social 
life.23 Paracetamol, the analgesia that is most commonly 
used, is graded as a “weak” analgesia on the World Health 
Organization analgesia ladder.24 The use of a β2 agonist to 
manage chest pain requires further investigation, as does 
the use of creams (assumed to be local analgesia). Pain 
assessment and management should be an important 
component of HIV care. HIV care services need to 
be strengthened, with a particular emphasis on pain 
recognition and management. Palliative care services stress 
the importance of healthcare providers having skills and 
knowledge in pain management, and could be a resource in 
the management of these children. Reasons for the low use 
of analgesia, despite a high prevalence of reported pain, 
must be further investigated.
In this study, pain was not associated with age, and this 
finding was in contrast with the findings of other studies 
that documented that younger children experienced more 
pain than older children.10 In our study, the duration of time 
on ART did not affect reported pain prevalence or pain 
type. However, in studies carried out on adults, it appeared 
that ART reduced pain.25 Those children with a low CD4 
experienced the most pain, and this finding is similar to the 
findings of previous studies.16 The majority of children in this 
study were on a first-line ART regimen, that includes the 
use of stavudine. The South African National Department of 
Health’s latest guidelines for ART have replaced stavudine 
with abacavir,26 due to toxicity which includes peripheral 
neuropathy associated with stavudine use. These 
guidelines were rolled out in June 2010, and it is of concern 
that by December 2010, only nine (2.1%) children were on 
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the regimen that included abacavir. However, this may be 
explained by bias introduced by the sampling method used.
The head has been reported as a common site of pain in HIV 
infection.4,7 In this study, too, the most common pain was 
reportedly that of headaches, according to the caregivers. 
The sources of headache may be multiple. For example, 
sinusitis, intracranial infections, referred pain, advanced-
stage HIV infection and the side-effects of ART may all cause 
headaches, and further research is required to clarify the 
underlying causes. Because of the nature of this study, it 
was not possible to determine the origin of the headaches. 
Similarly, further research needs to be carried out to clarify 
the cause of pain in other sites, e.g. abdominal and chest 
pain.  
Symptoms suggestive of neuropathic pain were found in 15 
(3.6%) children. This prevalence is lower than that found in 
an adult population.9 A minority of these children was given 
analgesia that was specific for neuropathic pain, and this 
requires further study. 
Study limitations
This was an exploratory study, and highlights areas for 
further research. The study was conducted over a relatively 
short period, and it may be that, over time, the pain profile 
alters on ART. For example, in those children who were just 
starting ART, it was expected that pain due to opportunistic 
infections would decline as the immune system recovered, 
and as opportunistic infections were treated. A convenience 
sampling strategy was employed, and although patients 
presented in a random order to the clinic, the pain profile of 
those who were not sampled may differ substantially from 
the pain profile of those who were. Caregivers was asked 
to assess pain in children using the WBFS, a tool designed 
to be used by children to report pain.19 Although studies 
have shown that there is concordance between caregiver 
assessment of pain, and a child’s own assessment of 
pain,10,17,20 the use of the WBFS tool in this manner may 
have introduced information bias. The researchers made 
several assumptions, including the belief that pain in the 
limbs and feet was due to neuropathy, which may not 
have been the case. Other limitations include the fact that 
no distinction was made between acute and chronic pain, 
and no follow-up was undertaken to see whether pain was 
reduced at subsequent visits. The non-distinction between 
acute and chronic pain impacts greatly on the assessment 
and management of pain, and it is recommended that future 
studies focus more on this distinction. 
Conclusion
This exploratory study revealed that pain in children on 
ART is common, and can interfere with their daily living 
activities. In general, pain was significant, as indicated by 
the WBFS, and pain was more common in children who had 
a lower CD4 count. The study indicates that analgesia may 
not be appropriate. For example, paracetamol was offered 
in instances in which pain was reported to be significant. 
There is a need for further research, and in particular, in 
assessing whether pain is acute or chronic. 
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